These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35282012)

  • 41. Characterization and mechanisms of anti-influenza virus metabolites isolated from the Vietnamese medicinal plant Polygonum chinense.
    Tran TT; Kim M; Jang Y; Lee HW; Nguyen HT; Nguyen TN; Park HW; Le Dang Q; Kim JC
    BMC Complement Altern Med; 2017 Mar; 17(1):162. PubMed ID: 28327126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.
    Kati WM; Montgomery D; Carrick R; Gubareva L; Maring C; McDaniel K; Steffy K; Molla A; Hayden F; Kempf D; Kohlbrenner W
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1014-21. PubMed ID: 11897583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.
    Tarbet EB; Hamilton S; Vollmer AH; Luttick A; Ng WC; Pryor M; Hurst BL; Crawford S; Smee DF; Tucker SP
    J Antimicrob Chemother; 2014 Aug; 69(8):2164-74. PubMed ID: 24777908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
    Gohil DJ; Kothari ST; Shinde PS; Chintakrindi AS; Meharunkar R; Warke RV; Kanyalkar MA; Chowdhary AS; Deshmukh RA
    Infect Genet Evol; 2015 Jan; 29():75-81. PubMed ID: 25461259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function.
    Jang Y; Shin JS; Yoon YS; Go YY; Lee HW; Kwon OS; Park S; Park MS; Kim M
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.
    Bauer K; Dürrwald R; Schlegel M; Pfarr K; Topf D; Wiesener N; Dahse HM; Wutzler P; Schmidtke M
    Med Microbiol Immunol; 2012 Feb; 201(1):61-72. PubMed ID: 21688167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant yeast as a functional tool for understanding bitterness and cucurbitacin biosynthesis in watermelon (Citrullus spp.).
    Davidovich-Rikanati R; Shalev L; Baranes N; Meir A; Itkin M; Cohen S; Zimbler K; Portnoy V; Ebizuka Y; Shibuya M; Burger Y; Katzir N; Schaffer AA; Lewinsohn E; Tadmor Y
    Yeast; 2015 Jan; 32(1):103-14. PubMed ID: 25308777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Grafting for Management of Southern Root-Knot Nematode, Meloidogyne incognita, in Watermelon.
    Thies JA; Ariss JJ; Hassell RL; Olson S; Kousik CS; Levi A
    Plant Dis; 2010 Oct; 94(10):1195-1199. PubMed ID: 30743610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.
    Rahman M; Hoque SA; Islam MA; Rahman SR
    Virus Genes; 2017 Jun; 53(3):377-385. PubMed ID: 28401407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic Analysis of Fruit Quality Traits in Sweet Watermelon (
    Mashilo J; Shimelis H; Ngwepe RM; Thungo Z
    Front Plant Sci; 2022; 13():834696. PubMed ID: 35392511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiviral Activity and Underlying Action Mechanism of Euglena Extract against Influenza Virus.
    Nakashima A; Horio Y; Suzuki K; Isegawa Y
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
    Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
    J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
    Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative mapping in watermelon [Citrullus lanatus (Thunb.) Matsum. et Nakai].
    Sandlin K; Prothro J; Heesacker A; Khalilian N; Okashah R; Xiang W; Bachlava E; Caldwell DG; Taylor CA; Seymour DK; White V; Chan E; Tolla G; White C; Safran D; Graham E; Knapp S; McGregor C
    Theor Appl Genet; 2012 Dec; 125(8):1603-18. PubMed ID: 22875176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.
    Zhao X; Li R; Zhou Y; Xiao M; Ma C; Yang Z; Zeng S; Du Q; Yang C; Jiang H; Hu Y; Wang K; Mok CKP; Sun P; Dong J; Cui W; Wang J; Tu Y; Yang Z; Hu W
    J Med Chem; 2018 Jun; 61(12):5187-5198. PubMed ID: 29799746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.